Buscar
Mostrando ítems 1-10 de 162
Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft
(Ferrata Storti FoundationPaviaItália, 2002)
Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation
(Blackwell Publishing LtdOxfordInglaterra, 2003)
Hematopoietic stem cell transplantation: clinical use and perspectives
(SOC BIOLGIA CHILE, 2012)
Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of malignant and non-malignant diseases in children and adults. Initially developed as rescue therapy for a patient with cancer after ...
Late effects of chronic graft-vs.-host disease in minor salivary glands
(Blackwell PublishingOxfordInglaterra, 2005)
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
(Associação Brasileira de Divulgação Científica, 2002-07-01)
Fungal infection is one of the most important causes of morbidity and mortality in bone marrow transplant (BMT) recipients. The growing incidence of these infections is related to several factors including prolonged ...
Fusarium infection in hematopoietic stem cell transplant recipients
(Univ Chicago PressChicagoEUA, 2004)
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens
(Nature Publishing GroupLondonInglaterra, 2008)
Chimerism induction by nonmyeloablactive preconditioning and bone marrow infusion in rat small bowel transplantation
(Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia, 2003-01-01)
Em estudo recente demonstramos que a infusão de células da medula óssea do doador após o transplante intestinal não aumentou a sobrevida do enxerto quando se utilizou series curtas de drogas imunossupressoras. OBJETIVO: ...
Chimerism induction by nonmyeloablactive preconditioning and bone marrow infusion in rat small bowel transplantation
(Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia, 2003-01-01)
Em estudo recente demonstramos que a infusão de células da medula óssea do doador após o transplante intestinal não aumentou a sobrevida do enxerto quando se utilizou series curtas de drogas imunossupressoras. OBJETIVO: ...